Long-term Efficacy and Safety of Enzalutamide Monotherapyin Hormone-naive Prostate Cancer 3-Year Open-label Follow-up Results

B. Tombal; M. Borre; Per Rathenborg; P Werbrouck; H Van Poppel; A. Heidenreich; P Iversen; J Braeckman; J Heracek; B Baron; A Krivoshik; M Hirmand; M.R. Smith

Long-term Efficacy and Safety of Enzalutamide Monotherapyin Hormone-naive Prostate Cancer 3-Year Open-label Follow-up Results

B. Tombal, M. Borre, Per Rathenborg, P Werbrouck, H Van Poppel, A. Heidenreich, P Iversen, J Braeckman, J Heracek, B Baron, A Krivoshik, M Hirmand, M.R. Smith

Urinvejssygdomme

Originalsprog	Engelsk
Publikationsdato	16 feb. 2017
Status	Udgivet - 16 feb. 2017
Begivenhed	ASCO GU - Orlando, USA Varighed: 16 feb. 2017 → 18 feb. 2017

Konference

Konference	ASCO GU
Lokation	Orlando, USA
Periode	16/02/2017 → 18/02/2017

Citationsformater

@conference{4f6857bf5957418a9f49402ef9134726,

title = "Long-term Efficacy and Safety of Enzalutamide Monotherapyin Hormone-naive Prostate Cancer 3-Year Open-label Follow-up Results",

author = "B. Tombal and M. Borre and Per Rathenborg and P Werbrouck and {Van Poppel}, H and A. Heidenreich and P Iversen and J Braeckman and J Heracek and B Baron and A Krivoshik and M Hirmand and M.R. Smith",

year = "2017",

month = feb,

day = "16",

language = "English",

note = "ASCO GU ; Conference date: 16-02-2017 Through 18-02-2017",

}

TY - ABST

T1 - Long-term Efficacy and Safety of Enzalutamide Monotherapyin Hormone-naive Prostate Cancer 3-Year Open-label Follow-up Results

AU - Tombal, B.

AU - Borre, M.

AU - Rathenborg, Per

AU - Werbrouck, P

AU - Van Poppel, H

AU - Heidenreich, A.

AU - Iversen, P

AU - Braeckman, J

AU - Heracek, J

AU - Baron, B

AU - Krivoshik, A

AU - Hirmand, M

AU - Smith, M.R.

PY - 2017/2/16

Y1 - 2017/2/16

M3 - Conference abstract for conference

T2 - ASCO GU

Y2 - 16 February 2017 through 18 February 2017

ER -